NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01)

The summary for the NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01): -Purpose. This funding opportunity announcement (FOA) is targeted toward supporting well-designed, investigator-initiated Phase III Definitive Clinical Trials (DCT) to establish safe and effective treatments or interventions for communication disorders. A Phase III DCT proposed under this FOA should have the potential to provide a significant impact on clinical practice or public health policy if successful. It is expected that applicants for a Phase III DCT already have adequate pre-clinical and preliminary clinical data to support the Phase III DCT. Also, information necessary to address core design and clinical issues prior to the conduct of the Phase III DCT should have already been established, and a complete, detailed Manual of Procedures (MOP) has been developed. The MOP MUST be submitted as an appendix to the Phase III Definitive Clinical Trial application. The NIDCD Clinical Trial Planning Grant (R34) (PAR-08-203) and/or the NIDCD Phase I/II Preliminary Clinical Trial FOA (PAR-08-204) can be used to gather this information and prepare the MOP. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Awards for multicenter Phase III DCTs or awards of $500,000 or more in direct costs in any grant year will be converted to the cooperative grant award mechanism (U01). -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Federal Grant Title:	NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-08-205
Type of Funding:	Grant
CFDA Numbers:	93.173
CFDA Descriptions:	Research Related to Deafness and Communication Disorders
Current Application Deadline:	No deadline provided
Original Application Deadline:	Sep 07, 2012
Posted Date:	Jul 16, 2008
Creation Date:	Jul 16, 2008
Archive Date:	Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: For profit organizations other than small businesses Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) State governments Native American tribal organizations (other than Federally recognized tribal governments) County governments Native American tribal governments (Federally recognized) City or township governments Independent school districts Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Small businesses Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Medical Rehabilitation Research Resource (P50 Clinical Trial Optional); • Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Tr...; • BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Centr...; • NIDCD Patient-Oriented Research Grant (R21); • Cell Lineage and Developmental Studies in Hearing and Balance; • Structural Analyses of the Ligand-Binding Properties of Taste and Smell Receptors
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...